American Rhinologic Society

Type: Organization
Name: American Rhinologic Society
First reported Sep 03 2014 - Updated Sep 03 2014 - 1 reports

Intersect ENT Reports Second Quarter 2014 Results

MENLO PARK, Calif., Sept. 3, 2014 (GLOBE NEWSWIRE) -- Intersect ENT, Inc. ( Nasdaq:XENT ), a company dedicated to improving the quality of life for patients with ear, nose and throat conditions, today reported financial results for the second quarter ... [Published Good Day Sacramento - Sep 03 2014]

Quotes

"This is a remarkable time for Intersect ENT," said Lisa Earnhardt, president and chief executive officer. "We continue to make solid progress driving adoption of PROPEL and PROPEL mini, delivering another quarter of strong revenue growth with gross margins over 70%. We are also delighted to have completed our IPO, which facilitates our efforts to bring our steroid-releasing implant technology to many more patients by helping us to expand our commercial footprint as well as to advance our pipeline of novel products for use in the office setting. We are pleased to be addressing the debilitating symptoms of chronic sinusitis, a condition which affects one in eight adults in the U S and is a leading cause of lost work productivity for employers."

More Content

All (1) | News (1) | Reports (0) | Blogs (0) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Intersect ENT Reports Second Quarter 2014 Results [Published Good Day Sacramento - Sep 03 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.